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CDC Guidance on the Use of Influenza Antiviral Agents and 
Rapid Influenza Diagnostic Tests During the 2010-2011 
Influenza Season
Summary
As influenza activity increases in the United States, clinicians are urged to consult CDC 
guidance on the use of influenza antiviral agents and rapid influenza diagnostic tests this season. 
Updated recommendations on the use of antiviral medications will be published in an upcoming 
Morbidity and Mortality Weekly Report (MMWR), but an interim version of the 
recommendations is currently available on CDC's website at
http://www.cdc.gov/flu/professionals/antivirals/index.htm. The updated guidance for health care 
professionals on the use of rapid influenza diagnostic tests is available at
http://www.cdc.gov/flu/professionals/diagnosis/clinician guidance ridt.htm. For the most recent 




The recommendations on the use of influenza antiviral agents contain information on treatment 
and chemoprophylaxis of influenza virus infection, and also provide a summary of the 
effectiveness and safety of antiviral medications. Highlights include recommendations for the 
following:
• early empiric antiviral treatment of suspected or confirmed influenza among people with 
severe, complicated, or progressive illness or those hospitalized for influenza;
• early empiric antiviral treatment of suspected or confirmed influenza among people at higher 
risk for influenza complications;
• use of either oseltamivir or zanamivir for influenza A and B treatment or chemoprophylaxis,
and recommendations not to use rimantadine or amantadine as influenza antiviral
medications due to high levels of resistance to these medications among circulating influenza 
A viruses;
• use of antiviral medications among children younger than 1 year of age;
• use of local data on influenza virus circulation and influenza testing of respiratory specimens
from patients with suspected influenza, when available, to help inform clinicians about 
influenza circulation; and
• consideration of antiviral treatment for any previously healthy, non high-risk symptomatic 
outpatient with confirmed or suspected influenza, based upon clinical judgment, if treatment 
can be initiated within 48 hours of illness onset.
Antiviral Agents Guidance:
The recommendations on the use of influenza antiviral agents contain information on treatment 
and chemoprophylaxis of influenza virus infection, and also provide a summary of the 
effectiveness and safety of antiviral medications. Highlights include recommendations for the 
following:
• use of rapid influenza diagnostic tests when a positive result will change the clinical 
management of patients or change outbreak control strategies in a population, especially if 
the setting includes hospitalized patients or persons at high risk for influenza-associated 
complications;
• avoiding the use of negative rapid test results to guide decisions regarding treating patients 
with influenza antiviral medications due to the suboptimal sensitivity of rapid tests;
• evaluation of rapid diagnostic test results in the context of other available clinical and 
epidemiological information; and
• consideration of further influenza laboratory testing in the following circumstances:
o when a patient tests negative by rapid test during periods of high influenza activity; 
o when a patients tests positive by rapid test during periods of low influenza activity; or
o when a patient has had recent close exposure to pigs, poultry, or other animals and novel 
influenza A virus infection is possible.
For More Information
For Information on Use of Influenza Antiviral Agents During the 2010-2011 Influenza Season 
go to: http://www.cdc.gov/flu/professionals/antivirals/index.htm
For Information on Use of Rapid Influenza Diagnostic Tests for the 2010-2011 Influenza Season 
go to: http://www.cdc.gov/flu/professionals/diagnosis/
For other inquiries, please visit http://www.cdc.gov/flu or call CDC's toll-free information line, 
800-CDC-INFO (800-232-4636)
The Centers for Disease Control and Prevention (CDC) protects people's health and safety by 
preventing and controlling diseases and injuries; enhances health decisions by providing 
credible information on critical health issues; and promotes healthy living through strong 
partnerships with local, national and international organizations.
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• Health Advisory: Provides important information for a specific incident or situation; may 
not require immediate action. Example: HAN00346
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